Hemoglobin A-2: Responsible for Carrying Oxygen in Red Blood Cells

Target Name: Hemoglobin A-2 (HbA-2)

NCBI ID: P18176

Hemoglobin A-2 (HbA-2)

Other Name(s): None

Hemoglobin A-2: Responsible for Carrying Oxygen in Red Blood Cells

Hemoglobin A-2 (HbA-2), also known as HBA-2 or 伪-2-Hb, is a protein found in red blood cells (RBCs) that is responsible for carrying oxygen from the lungs to the rest of the body. It is a key component of hemoglobin, which is a protein that gives red blood cells their red color.

HbA-2 is a glycoprotein, which means it consists of a protein that is covalently bound to a sugar called glutamic acid. It has a molecular weight of approximately 17 kDa and is made up of four polypeptide chains.

HbA-2 is found in all human beings and is produced by the bone marrow. It is a key protein for the production of red blood cells, which are responsible for carrying oxygen from the lungs to the rest of the body. HbA-2 is also involved in the regulation of the production of red blood cells, as well as the maintenance of the structure and function of red blood cells.

One of the functions of HbA-2 is to transport oxygen from the lungs to the rest of the body. When a person breathes in oxygen, it travels to the lungs where it is exchanged with carbon dioxide. HbA-2 is responsible for carrying this oxygen to the body's cells, where it is used to generate energy.

HbA-2 is also involved in the regulation of the production of red blood cells. It plays a key role in the process of hematopoiesis, which is the process by which new blood cells are produced in the bone marrow. HbA-2 helps to control the production of red blood cells and ensures that they are properly mature and functional.

In addition to its role in the production and regulation of red blood cells, HbA-2 is also involved in the immune response. It is a key target for certain viruses, such as human immunodeficiency virus (HIV), which uses it as a source of fuel for the production of new virus particles.

HbA-2 is also a potential drug target for several diseases, including anemia, hemolytic anemia, and thalassemia. Anemia is a condition in which the number of red blood cells in the body is lower than normal, which can cause symptoms such as fatigue, weakness, and shortness of breath. HbA-2 has been shown to be an effective target for treating anemia by increasing the production of red blood cells in the bone marrow.

Hemolytic anemia is a condition in which the red blood cells are broken down and replaced with new ones, which can cause anemia. HbA-2 has been shown to be an effective target for treating hemolytic anemia by regulating the production of red blood cells in the bone marrow.

Thalassemia is a genetic disorder that affects the production of red blood cells. It can cause anemia, as well as other symptoms such as fatigue and jaundice. HbA-2 has been shown to be an effective target for treating thalassemia by increasing the production of red blood cells in the bone marrow.

In conclusion, HbA-2 is a protein that is found in red blood cells that is responsible for carrying oxygen from the lungs to the rest of the body. It is a key component of hemoglobin and is involved in the production and regulation of red blood cells. It is also involved in the immune response and has been shown to be an effective target for several diseases, including anemia, hem

Protein Name: Hemoglobin A-2 (HbA-2)

The "Hemoglobin A-2 (HbA-2) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Hemoglobin A-2 (HbA-2) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets